Treatment and long-term follow-up of children with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): Experience from the Tata Memorial Hospital pediatric CML cohort over 2 decades

Treatment and long-term follow-up of children with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): Experience from the Tata Memorial Hospital pediatric CML cohort over 2 decades

Bibliographic Details
Main Authors:	Nirmalya Roy Moulik, Ankita Pandey, Gaurav Chatterjee, Chetan Dhamne, Akanksha Chichra, Dhanlaxmy Shetty, Prashant Tembhare, Papagudi Subramanian, Nikhil Patkar, Gaurav Narula, Shripad Banavali
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124522004934

Similar Items

Outcome of pediatric relapsed refractory Hodgkin lymphoma experience from Tata Memorial Hospital , Mumbai
by: Ankita Pandey, et al.
Published: (2022-01-01)

P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)
by: Prashant Tembhare, et al.
Published: (2023-08-01)

Identifying regulators of chronic myeloid leukaemic (CML) stem cell quiescence and discovering effective novel therapies for CML relapse
by: Xu, Z
Published: (2022)

Molecular Monitoring of Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
by: Mehrdad Payandeh, et al.
Published: (2018-12-01)

Progress with interferon in CML--results of the MRC UK CML III study.
by: Shepherd, P, et al.
Published: (1996)

Molecular Pathogenesis and Treatment Strategies of Chronic Myeloid Leukemia (CML)
by: Rabia Khalid, et al.
Published: (2023-12-01)

P713: REAL-WORLD MANAGEMENT OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML): FIRST ANALYSIS FROM THE UK NATIONAL REGISTRY FOR CML
by: G. Nesr, et al.
Published: (2022-06-01)

International CML forum
by: A. G. Turkina
Published: (2022-11-01)

Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL)
by: Mehrdad Payandeh, et al.
Published: (2014-12-01)

BONE-MARROW TRANSPLANTATION USING UNRELATED DONORS FOR CML IN CHRONIC PHASE
by: Cullis, J, et al.
Published: (1991)

Targeting a chronic problem: elimination of cancer stem cells in CML.
by: Nerlov, C
Published: (2009)

Current treatment approaches in CML
by: Fausto Castagnetti, et al.
Published: (2019-06-01)

Characterization of the function of Calmodulin-like(CML) 23 and CML24 in the arabidopsis thaliana circadian clock /
by: Nur Izzati Mohd. Noh, author, et al.
Published: (2014)

BONE-MARROW TRANSPLANTATION FOR CHRONIC PHASE CML - THE ROLE OF T-CELL DEPLETION IN 1988
by: Mackinnon, S, et al.
Published: (1988)

P695: PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN CHRONIC PHASE CML
by: A. Bidikian, et al.
Published: (2022-06-01)

PENGARUH GIZI TERHADAP RESPON TERAPI PASIEN CHRONIC MYELOCYSTIC LEUKIMIA (CML)
by: Asrini Safitri, et al.
Published: (2018-10-01)

Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients
by: Fahri Sahin, et al.
Published: (2013-09-01)

Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms
by: Daniela Zizioli, et al.
Published: (2021-02-01)

Asparginase associated pancreatitis in children with Pre-B-Acute lymphoblastic leukaemia (ALL): A six-year retrospective study from
by: Poonam Khemani, et al.
Published: (2022-01-01)

Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017
by: Michael Daskalakis, et al.
Published: (2021-12-01)

Characterization of the function of Calmodulin-like(CML) 23 and CML24 in the arabidopsis thaliana circadian clock [electronic resource] /
by: Nur Izzati Mohd. Noh, author
Published: (2014)

Standardization of 13-color high-sensitivity measurable residual disease (MRD) assessment in B-cell lymphoblastic leukemia (B-ALL) treated with novel anti-CD19 immunotherapies
by: Prashant Tembhare, et al.
Published: (2022-01-01)

Hybrid Dynamic CML with Modified Current Source (H-MDyCML): A Low-Power Dynamic MCML Style
by: Riya Jain, et al.
Published: (2021-01-01)

BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML) USING MATCHED UNRELATED DONORS
by: Mackinnon, S, et al.
Published: (1988)

BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML) USING MATCHED UNRELATED DONORS
by: Mackinnon, S, et al.
Published: (1988)

PB1973: MOLECULAR PATTERNS OF RESPONSE AFTER FRONTLINE TREATMENT IN CHRONIC MYELOID LEUKAEMIA (CML).
by: Harberth Fernandez-Leyva
Published: (2023-08-01)

P673: ASCIMINIB MANAGMENT IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH T315I MUTATION.
by: Elena Kuzmina, et al.
Published: (2023-08-01)

Treatment-free remission: A new goal for all chronic phase (CP)-CML patients
by: Delphine Rea
Published: (2018-06-01)

NGS in CML - New standard diagnostic procedure?
by: Susan Branford, et al.
Published: (2019-06-01)

PB1891: VARIANT PHILADELPHIA CHROMOSOME IN CML
by: N. Bouayed Abdelmoula, et al.
Published: (2022-06-01)

The expanding CML treatment landscape: an introspective commentary
by: Jeffrey H. Lipton
Published: (2023-09-01)

Comparison of the Transcriptomic Signatures in Pediatric and Adult CML
by: Minyoung Youn, et al.
Published: (2021-12-01)

Nilotinib - new step of success in CML therapy
by: E. G. Lomaia, et al.
Published: (2022-11-01)

CML ENGAGEMENT IN ENGLISH COMPETENCY FOR TVET EDUCATORS
by: Nor Yazi, Khamis, et al.
Published: (2024)

UNLEASHING THE POWER OF CML THE JOURNEY TO EKSA AWARD
by: Fathiah Izzati, Mohammad Fadzillah, et al.
Published: (2024)

The new European leukemianet recommendations for treating CML
by: Rüdiger Hehlmann
Published: (2020-10-01)

Autografting for patients with CML in chronic phase: an update. Hammersmith BMT Team LRF Centre for Adult Leukaemia.
by: Hoyle, C, et al.
Published: (1994)

S150: BIOLOGY AND FUNCTION OF CIRCULAR PCMDT1 IN CHRONIC MYELOID LEUKEMIA IN BLAST CRISIS (CML-BC)
by: A. Prathap Urs, et al.
Published: (2022-06-01)

Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: A Study from the International Registry of Childhood CML
by: Frédéric Millot, et al.
Published: (2021-08-01)

Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
by: Erin Clapper, et al.
Published: (2020-03-01)